Infants exposed to opioids and psychotropic drugs during pregnancy have a 30% to 60% higher risk of experiencing neonatal withdrawal, a study has found. That risk doubles when multiple psychotropic ...

On learning last year she was pregnant with her second child, Cailyn Morreale was overcome with fear and trepidation. “I was so scared,” said Morreale, a resident of the small western North Carolina ...

Dallas, TX, March 24, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal phase II clinical trial, offering hope to ...

A new study into the race and socio-demographics of newborns with symptoms of opioid withdrawal shows that it is disproportionately higher among white newborns whose mothers are Medicaid enrollees and ...

As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS) – a condition that affects infants whose mothers used opioids during pregnancy – has risen ...

(MPSC), a company that specializes in the development of AI predictive analytics for the neonatal intensive care unit (NICU), has been granted Breakthrough Device designation by the US FDA for its ...

Judges on West Virginia’s intermediate appeals court heard arguments about whether lawsuits over babies experiencing the effects of addiction because they were exposed to drugs in the womb was ...

While pregnant with her second child, Cailyn Morreale was assured by her care team that she did not need to discontinue buprenorphine and that her baby would be assessed and monitored using the Eat, ...

CHARLOTTESVILLE, VIRGINIA, USA, July 22, 2024 /EINPresswire.com/ -- Medical Predictive Science Corporation (MPSC), a company that specializes in the development of AI ...